journal article·2021-09

Preparation and characterization of spray‐dried granulated bioactive glass micron spheres

Liu‐Gu Chen, Yu‐Hsuan Huang, Yu‐Jen Chou

Publisher page

Abstract

Abstract Owing to its superior bioactivity, biocompatibility, and biodegradability, bioactive glass (BG) has been attracting significant attention within biomedical science fields. However, BG powders with variable particle sizes are required targeting different applications, such as dermal fillers. Thus, in this study, granulated BG powders were prepared via the spray drying and granulation method. Size‐controlled BG micron sphere with diameters of up to tens of microns can be mass‐produced and their phase information, particle morphology, and specific surface area were characterized via X‐ray diffraction, scanning electron microscopy, and nitrogen adsorption/desorption isotherm, respectively. In addition, the in vitro bioactivity was evaluated following Kokubo's protocol, and the formation of a hydroxyapatite (HA) layer after immersion into the simulated body fluid was confirmed via energy‐dispersive and Fourier transform infrared spectroscopy. The cytotoxicity was examined using a 3‐(4, 5‐dimethylthiazol‐2‐yl)‐2, 5‐diphenyltetrazolium bromide assay. Finally, the resulting morphologies and corresponding properties are shown, and the related mechanisms are discussed.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Facial Trauma and Fracture Management · Dental Implant Techniques and Outcomes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Engineering and System Science National Tsing Hua University Hsinchu Taiwan

Department of Mechanical Engineering National Taiwan University of Science and Technology Taipei Taiwan

Funding

Ministry of Science and Technology, Taiwan

References (41)

Show source-provided references
1. 10.1002/jbm.82005061110.1002/jbm.820050611 ↗
2. 10.1111/j.1151-2916.1991.tb07132.x10.1111/j.1151-2916.1991.tb07132.x ↗
3. 10.1016/0272-8842(95)00126-310.1016/0272-8842(95)00126-3 ↗
4. 10.1002/jab.77002040310.1002/jab.770020403 ↗
5. 10.1039/b007852m10.1039/b007852m ↗
6. 10.1016/j.actbio.2011.05.03310.1016/j.actbio.2011.05.033 ↗
7. 10.1177/002203451455925010.1177/0022034514559250 ↗
8. 10.1021/acs.jpcc.5b0780410.1021/acs.jpcc.5b07804 ↗
9. 10.1016/j.jconrel.2005.11.00210.1016/j.jconrel.2005.11.002 ↗
10. 10.1089/ten.tea.2010.029810.1089/ten.tea.2010.0298 ↗
11. 10.2310/6350.2005.3123610.2310/6350.2005.31236 ↗
12. 10.1097/01.icu.0000243021.20499.4b10.1097/01.icu.0000243021.20499.4b ↗
13. 10.1046/j.1524-4725.2002.01273.x10.1046/j.1524-4725.2002.01273.x ↗
14. 10.1111/j.1151-2916.1976.tb09382.x10.1111/j.1151-2916.1976.tb09382.x ↗
15. 10.1016/B978-0-08-102451-5.00006-810.1016/B978-0-08-102451-5.00006-8 ↗
16. 10.1016/j.jcis.2019.04.01610.1016/j.jcis.2019.04.016 ↗
17. 10.1111/ijac.1287310.1111/ijac.12873 ↗
18. 10.1016/j.msec.2010.02.00610.1016/j.msec.2010.02.006 ↗
19. 10.1007/s11051-012-1299-110.1007/s11051-012-1299-1 ↗
20. 10.3390/ma1005048810.3390/ma10050488 ↗
21. 10.1016/j.sder.2004.09.00510.1016/j.sder.2004.09.005 ↗
22. 10.1016/j.jaerosci.2007.04.00510.1016/j.jaerosci.2007.04.005 ↗
23. 10.1007/s10853-017-1026-510.1007/s10853-017-1026-5 ↗
24. 10.3390/app901001910.3390/app9010019 ↗
25. 10.1016/j.ceramint.2016.05.17610.1016/j.ceramint.2016.05.176 ↗
26. 10.1177/19322968080020061010.1177/193229680800200610 ↗
27. 10.3390/polym1101017110.3390/polym11010171 ↗
28. 10.1002/jbm.82024030610.1002/jbm.820240306 ↗
29. ISO 10993‐5: Biological evaluation of medical devices. Part 5: Tests for in vitro cytotoxicity.International Organization for Standardization;2009.
30. 10.3353/omp.15.4510.3353/omp.15.45 ↗
31. 10.1016/S0022-3093(02)01637-X10.1016/S0022-3093(02)01637-X ↗
32. 10.1021/ic50131a03910.1021/ic50131a039 ↗
33. 10.1111/j.1151-2916.1993.tb04007.x10.1111/j.1151-2916.1993.tb04007.x ↗
34. 10.1016/j.powtec.2014.05.05610.1016/j.powtec.2014.05.056 ↗
35. 10.1007/s11051-012-0879-410.1007/s11051-012-0879-4 ↗
36. 10.1016/j.xphs.2019.08.00810.1016/j.xphs.2019.08.008 ↗
37. 10.1023/A:100883471221210.1023/A:1008834712212 ↗
38. Investigation of the hydroxyapatite growth on bioactive glass surface
39. 10.1038/ncb1203-104110.1038/ncb1203-1041 ↗
40. Size‐dependent cytotoxic effects of amorphous silica nanoparticles on langerhans cells
41. 10.1002/smll.20080046110.1002/smll.200800461 ↗